Bausch Health Companies Inc. (NYSE:BHC) announced the availability of CABTREO gel for acne treatment in Nova Scotia and Ontario’s public drug plans. The gel is also accessible through federal drug plans for Indigenous populations and the Correctional Service of Canada.

CABTREO is a triple-combination topical treatment for acne approved by Health Canada, offering antibiotic, retinoid, and antibacterial action mechanisms. Bausch Health Companies Inc. (NYSE:BHC) develops and markets a variety of pharmaceuticals, over-the-counter products, and medical devices through different segments.

Investors are eyeing BHC’s potential, but some believe AI stocks offer better returns. For those interested in undervalued AI stock options, a free report on the best short-term AI stock is available. Explore more investment opportunities with 30 stocks that could double in 3 years and 11 hidden AI stocks to consider now.

Read more at Yahoo Finance: Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel